Copyright ©ERS Journals Ltd 2007 Pulmonary Mycobacterium avium complex infection: association with NRAMP1 polymorphisms1 Dept of Respiratory Diseases, Research Institute, and 4 Division of Respiratory Disease, International Medical Center of Japan, and Divisions of 2 Respiratory Disease, and 3 Clinical Research, National Hospital Organization Tokyo Hospital, Tokyo, Japan. CORRESPONDENCE: N. Keicho, Dept of Respiratory Diseases, Research Institute, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan. Fax: 81 332071038. E-mail: keicho{at}ri.imcj.go.jp Keywords: Mannose binding lectin, Mycobacterium avium complex, natural resistance-associated macrophage protein 1, vitamin D receptor
Received: March 25, 2006
The present study aimed to elucidate risk factors for nonimmunocompromised pulmonary Mycobacterium avium complex (MAC) infection. Epidemiological data and variations of candidate genes for mycobacterial diseases were analysed in 111 patients with pulmonary MAC infection. Four polymorphisms of the human natural resistance-associated macrophage protein (NRAMP)1 gene, the 5'(GT)n, 469+14 G/C, D543N and the 3'untranslated region (3'TGTG) insertion/deletion, were genotyped using PCR-based methods. Fok I and Taq I polymorphisms of the vitamin D receptor gene and -221 X/Y and codon 54 A/B polymorphisms of the mannose binding lectin gene were also evaluated. Females were more susceptible to MAC infection mainly affecting the right middle lobe or lingular segment of the lung. Patients' residence at the onset of the disease was distributed evenly irrespective of a waterfront or city water supply system. As compared with homozygotes for major alleles of the D543N and TGTG insertion/deletion polymorphism of the NRAMP1 gene, heterozygotes containing minor alleles were less often observed in MAC cases than in controls. This genetic effect was more significant in patients without comorbidity but not in patients with comorbidity. Other polymorphisms did not show any association with the MAC infection. The human natural resistance-associated macrophage protein 1 gene might be involved in susceptibility to pulmonary Mycobacterium avium complex infection. Pulmonary Mycobacterium avium complex (MAC) infection causes chronic pulmonary diseases. MAC occurs in the natural environment and the common source of infection appears to be water, soil or dust, with human-to-human transmission considered uncommon 13. As an opportunistic pathogen, MAC causes disseminated disease in immmunocompromised hosts, such as individuals with HIV infection. However, there is evidence that the number of patients with MAC infection is increasing not only in AIDS-endemic areas but also in many other areas of the world, including Japan 4, 5. Patients with underlying chronic lung diseases, such as inactive tuberculosis (TB), chronic obstructive pulmonary disease or cystic fibrosis, sometimes develop pulmonary MAC infection 5, which may be explained by significant damage to local immunity in the lung. Individuals without any obvious immunosuppressive state or any evidence of previous pulmonary disease, especially middle-aged to elderly females, also develop pulmonary MAC infections 6, 7. In most patients, a radiographical pattern consisting of small centrilobular nodules corresponding to foci of granulomatous inflammation and bronchiectasis of the middle lobe, lingular segment and other lobes can be seen 8, 9. These lesions often expand, causing impairment of pulmonary function and, in severe cases where the treatment is difficult, a fatal outcome may occur 6. A recent study implied that the sibling risk for MAC infection is much higher than its population prevalence estimated from an incidence rate of 3.52 per 100,000 in Japan 4, 10. A complex interaction between genetic and environmental factors is thus considered. The natural resistance-associated macrophage protein (Nramp)1 gene determines susceptibility to intracellular pathogens in mice 11. A human homologue, NRAMP1, recently designated as solute carrier 11a1, was identified in the region of 2q35, and variations of the NRAMP1 gene were studied for mycobacterial diseases including TB and leprosy 1216. In cases of MAC infection, the number of subjects is small 10, 17, 18, and, to date, no population-based studies have investigated the contribution of NRAMP1 to pulmonary MAC infection with a relatively large sample size. As other candidate genes, polymorphisms of the vitamin D receptor (VDR) and mannose binding lectin (MBL) genes are known to be associated with TB 19, 20, presumably playing an important role in intracellular growth of the pathogen. Thus, the clinico-epidemiological background of the disease was characterised and a casecontrol association study was conducted to determine whether polymorphisms of the three representative candidate genes are involved in the development of pulmonary MAC infection.
Study subjects In total, 111 Japanese cases of pulmonary MAC infection were included in the current study. Written informed consent was obtained from each individual. The present study protocol was approved by the local ethical committees. Out of the 111 subjects, 86 patients were from the International Medical Center of Japan and 25 were from the National Hospital Organization Tokyo Hospital (both Tokyo, Japan). A group of 177 healthy Japanese volunteers (control 1) were also obtained from the same region as the patients and were genotyped as controls. Only when a significant association (p<0.05) was obtained in control 1, was control 2 (n = 247) further tested. The 1997 American Thoracic Society (ATS) statement was followed to make a diagnosis of MAC pulmonary disease 3. Briefly, all patients had clinical manifestations, small nodules with or without bronchiectasis on computed tomography images and positive smears or cultures of bacteria from at least three sputum samples, or histological or bacteriological evidence of the disease from bronchial or lung samples. Patients with obvious immunodeficiency, such as haematological malignancy, those who are under immunosuppressive therapy or those with HIV infection were excluded from this study. Comorbidity was described on the basis of a physician's diagnosis. Differentiation of cultured mycobaterial species was routinely performed by PCR (AMPLICOR Mycobacterium tests; Roche Diagnostics, Basel, Switzerland). Clinical profiles and backgrounds of all subjects were extracted from medical records and interviews performed by trained medical staff.
Genotyping of NRAMP1 polymorphisms
Genotyping of VDR and MBL polymorphisms Two polymorphisms of the MBL gene, the -221 X/Y (rs7096206) in the promoter and codon 54 A/B (rs1800450) in exon 1, were genotyped by digestion of PCR fragments with the Btg I and Ban I enzymes, respectively. The PCR primer pair used was 5'-ACCTGGGTTTCCACTCATTCTCAT-3' and 5'-CCCCAGGCAGTTTCCTCTGGAAGG-3'. Other known structural polymorphisms, C (codon 57; rs1800451) and D (codon 52; rs5030737), were not tested in the current study, as their frequencies have been reported to be extremely low in Asian populations 24. All genotypes were determined by agarose gel electrophoresis of digested PCR fragments.
Statistical analysis
Characteristics of patients with pulmonary MAC infection In total, 111 patients were involved in the current study (table 1
Residence at onset of pulmonary MAC infection To examine whether the development of pulmonary MAC infection is related to an urban water supply, the locations at which the first signs and symptoms of MAC infection were noted, were plotted on a regional map of Tokyo, Japan (fig. 1
Pulmonary MAC infection and NRAMP1 polymorphisms The results of casecontrol studies in patients with pulmonary MAC infection at four polymorphic loci of NRAMP1 are shown in table 2
NRAMP1 D543N polymorphism and subgroups of pulmonary MAC infection Differences of genotypic distribution of D543N and TGTG insertion/deletion polymorphism between cases and controls led to the analysis of possible differences between subgroups of MAC cases and controls. The TGTG insertion/deletion polymorphism was in perfect linkage disequilibrium with D543N and the genotype distributions of D543N described in table 3
Pulmonary MAC infection and VDR polymorphisms Two polymorphisms of the VDR gene, the Fok I polymorphism in exon 3 and Taq I polymorphism in exon 10, were also analysed. Distributions of both polymorphisms were not different between MAC cases and controls (table 4
Pulmonary MAC infection and MBL polymorphisms Two polymorphisms of the MBL gene, -221 X/Y and codon 54 A/B polymorphisms were also tested. The distribution of both polymorphisms was not different between MAC cases and controls (table 5
In general, interaction among pathogens, host factors and transmission routes are considered important for the development of infectious diseases. Although one report suggested that a familial aggregation of the disease is not caused by a single source of a particular virulent strain 10, molecular genetics of MAC causing pulmonary disease is rather limited. When the mode of transmission of MAC is considered, a hospital water system or home water supply could represent a risk of MAC infection 2. One study in South-East America 1 demonstrated that natural waters might be a source of pathogenic mycobacteria that can be transferred from water to air. The current authors plotted the place of residence of the subjects at the onset of the disease. Although this is not an all-embracing cohort study, it may be possible to conclude that the distribution of subjects' residence is not concentrated in a specific city water system or waterfront. Genetic predisposition would be involved in the development of pulmonary MAC infection for the following reasons. In the past, mutational defects of several genes were identified as a cause of congenital cellular immune deficiency in several families of a disseminated form of MAC infection 30. Furthermore, two studies showed that the human leukocyte antigen (HLA) DR6 allele, encoded by the HLA-DRB1 gene, or an Asian HLA haplotype including DR6 is associated with sporadic cases of pulmonary MAC infection in the Japanese population 31, 32. On the basis of strong influence of a mutation in the NRAMP1 gene on susceptibility to intracellular pathogens in mice, there has been considerable interest in the relevance of the human homologue, NRAMP1, in susceptibility to human mycobacterial infection 1216. With regard to the MAC infection, there are only a few reports with small sample sizes. Huang et al. 17 analysed the 5'(GT)n, D543N and 3'UTR insertion/deletion polymorphisms of the NRAMP1 gene in eight patients with MAC and were unable to find any particular characteristics of allele patterns. Tanaka et al. 10 analysed the coding region of the NRAMP1 gene in two Japanese families with pulmonary MAC infection, but were unsuccessful in finding any obvious abnormalities indicating immune deficiency. More recently, Koh et al. 18 reported a strong association between nontuberculous mycobacterial (NTM) lung disease including 18 patients with MAC infection and polymorphisms of the NRAMP1 gene in a Korean population. However, this data should be interpreted with care, as it is estimated that at least seven (17.1%) of the 41 NTM patients possessed the 543-D and 3'UTR TGTG deletion haplotype, which had been thought to be rare in Asians 13, 16, 21, 33, including Korean TB patients 14. Some factors unique to their study population, such as population stratification, might also have had an effect on the results, while the authors described uniformity of ethnicity. To the current authors' knowledge, this is the first large-scale study in which >100 blood samples were collected for analysis of the candidate genes for pulmonary MAC infection. To exclude the possibility of false positives owing to a biased genotypic distribution of the controls, another set of controls were also tested and again significant association was observed. The allele frequency of the 543-N and TGTG deletion of 3'UTR were significantly lower in the MAC group than in controls. Although the amino acid change in the coding region and 3'UTR polymorphism of the NRAMP1 gene might influence the function and mRNA levels of the gene, respectively, the functional significance of these polymorphisms has not yet been investigated extensively. It is not surprising that the (GT)n promoter polymorphism of the NRAMP1 gene was not associated with MAC infection in the present study, as earlier studies analysing genomic structure around the NRAMP1 gene demonstrated that linkage disequilibrium is not strong enough between the 5' and 3' end of the gene 12, 21, 33, namely the (GT)n repeats and D543N/TGTG polymorphisms, although the D543N and TGTG insertion/deletion polymorphism are in perfect linkage disequilibrium. It is interesting that in a West African population, the same 3'UTR deletion allele was similarly low in subjects with a paucibacillary tuberculoid form of leprosy, where a T-helper cell (Th)1-type response is more predominant, than in multibacillary form, which is associated with a Th2-type immune response 15. Conversely, however, the study by Bellamy et al. 12 clearly showed that all four polymorphisms were associated with smear-positive TB and the 543-N and TGTG deletion showed a more positive association with TB in Gambians, whereas, in a Cambodian population, the 543-N and TGTG deletion showed a negative association with active TB 16. Apparently divergent findings may be explained by the presence of another possible susceptibility variant 33. In the study by Bellamy et al. 12, a strong association was demonstrated by combined analysis of the INT4 and 3'UTR variants. However, in the current study, the GC/+del allele did not increase the risk for development of pulmonary MAC disease. The haplotype carrying the INT4-C allele and 3'UTR-del allele, which were both reported as susceptible alleles in the study of Bellamy et al. 12, might not exist in the Japanese population according to the current frequency estimation. This might partly explain the differences between the present study and the report from an African population 12. The present authors classified patients into two groups, with or without predisposing risk factors, as described in the 1997 ATS statement 3. Most MAC patients without a predisposing condition were elderly females, and the right middle lobe or lingular segment of the lung was mainly affected. This appears to be one of the characteristics of pulmonary MAC infection without comorbidity 68. Although the mechanism is unknown, changes in hormonal balance accompanied with ageing might be involved in the development of the disease 34. The NRAMP1 polymorphism showed a relatively strong association with MAC infection where there is no predisposing condition or in cases where the main lesion is limited to the right middle lobe or lingular segment of the lung. In contrast, the subgroup without this phenotype did not show significant associations. It is consistent with the notion that a certain genetic predisposition underlies this particular phenotype in affected individuals. When the results of previous and future studies on MAC infection are assessed, this phenotypic effect should be taken into account.
The current authors investigated the human natural resistance-associated macrophage protein 1, vitamin D receptor and mannose binding lectin gene polymorphisms, previously reported as candidate genes determining susceptibility to mycobacterial infection, and demonstrated a possible influence of the natural resistance-associated macrophage protein 1 polymorphisms on the development of pulmonary Mycobacterium avium complex infection. Possible genetic risk factors that permit infection with Mycobacterium avium complex in otherwise normal individuals could be targeted for future therapeutic intervention.
This work was supported in part by research grants for Research on the Human Genome, Tissue Engineering and Food Biotechnology from the Ministry of Health, Labour and Welfare of Japan, by the Organization for Pharmaceutical Safety and Research in 2002 and 2003 and by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan in 20012005.
The authors wish to thank: A. Mikami, S. Izumi, M. Kamimura, H. Kawada and A. Yoshizawa (International Medical Center of Japan, Tokyo, Japan), and Y. Kawabe, K. Masuda, M. Nishiyama and Y. Tanaka (National Hospital Organization Tokyo Hospital, Tokyo, Japan) for making the patients under their care available; M. Okochi (International Medical Center of Japan) for her technical assistance; and K. Tanabe (International Medical Center of Japan) for critical reading the manuscript. The authors would especially like to thank S. Akagawa and N. Nagayama (National Hospital Organization Tokyo Hospital) for their continuous encouragement.
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||